| Greenberg SA
Comment on alemtuzumab and inclusion body myositis. [JOURNAL ARTICLE]
Brain 2009 Nov 5.
Full Citation | Publisher Full Text | Find Related Articles |
| Dalakas MC, Rakocevic G, Schmidt J, et al.
Reply to: Comment on alemtuzumab and inclusion body myositis. [JOURNAL ARTICLE]
Brain 2009 Nov 5.
Full Citation | Publisher Full Text | Find Related Articles |
| Teuteberg JJ, Shullo MA, Zomak R, et al.
Alemtuzumab Induction Prior to Cardiac Transplantation with Lower Intensity Maintenance Immunosuppression: One-Year Outcomes. [JOURNAL ARTICLE]
Am J Transplant 2009 Nov 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Jones J, Coles A
Spotlight on alemtuzumab. [Journal Article]
Int MS J 2009 Sep; 16(3):77-81.
Abstract | Full Citation |
| Anoop P, Wotherspoon A, Matutes E
Severe liver dysfunction from hepatitis C virus reactivation following alemtuzumab treatment for chronic lymphocytic leukaemia. [JOURNAL ARTICLE]
Br J Haematol 2009 Oct 28.
Full Citation | Find Related Articles |
| Byrd JC, Byrd JC, Peterson BL, et al.
Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: final report of Cancer and Leukemia Group B study 19901. [Journal Article]
Leuk Lymphoma 2009 Oct; 50(10):1589-96.
Abstract | Full Citation |
| Querfeld C, Mehta N, Rosen ST, et al.
Alemtuzumab for relapsed and refractory erythrodermic cutaneous T-cell lymphoma: a single institution experience from the Robert H. Lurie Comprehensive Cancer Center. [JOURNAL ARTICLE]
Leuk Lymphoma 2009 Oct 8.
Abstract | Full Citation | Find Related Articles |
| Morrison VA
Infectious Complications in Patients With Chronic Lymphocytic Leukemia: Pathogenesis, Spectrum of Infection, and Approaches to Prophylaxis. [JOURNAL ARTICLE]
Clin Lymphoma Myeloma 2009 Oct 1; 9(5):365-370.
Abstract | Full Citation |
| Maschmeyer G, Patterson TF
New Immunosuppressive Agents and Risk for Invasive Fungal Infections. [JOURNAL ARTICLE]
Curr Infect Dis Rep 2009 Nov; 11(6):435-438.
Abstract | Full Citation | Find Related Articles |
| Bauer MP, van Burgel ND, Marijt WA, et al.
Fever, Shock, and Pancytopenia in a Patient Treated with Alemtuzumab. [JOURNAL ARTICLE]
Clin Infect Dis 2009 Nov 15; 49(10):1540.
Full Citation | Find Related Articles |
   |
